Key Events This Week
6 Apr: Week opens at Rs.80.45
7 Apr: Mojo Grade upgraded to Sell from Strong Sell
8 Apr: Stock surges 4.01% amid positive technical momentum
10 Apr: Week closes at Rs.83.56, up 3.87% for the week
Monday, 6 April 2026: Week Opens Steady
Themis Medicare began the week at Rs.80.45, holding steady with a volume of 3,643 shares traded. The Sensex closed at 33,229.93, setting the stage for a volatile week ahead. No significant news impacted the stock on this day, with investors awaiting fresh developments.
Tuesday, 7 April 2026: Mojo Grade Upgrade Spurs Interest
The stock declined slightly by 1.06% to Rs.79.60 despite the MarketsMOJO upgrade from ‘Strong Sell’ to ‘Sell’ announced on 6 April. This upgrade was driven by improved technical indicators, including a shift from bearish to mildly bearish trends and a mildly bullish weekly MACD. However, fundamental weaknesses such as flat financial performance and negative profitability continued to weigh on sentiment.
Volume dropped to 1,398 shares, reflecting cautious trading. The Sensex gained 0.50%, closing at 33,395.05, outperforming Themis Medicare on the day. The upgrade signalled a modest easing of negative momentum but did not immediately translate into price gains.
Wednesday, 8 April 2026: Technical Momentum Drives 4.01% Rally
The stock rebounded strongly, rising 4.01% to Rs.82.79 on robust volume of 6,559 shares. This surge aligned with the mildly bullish weekly MACD and KST indicators, suggesting short-term momentum improvement. The Sensex also rallied sharply, gaining 3.88% to close at 34,690.59, reflecting broad market strength.
This day marked the week’s highest close for Themis Medicare, signalling a tentative recovery in technical sentiment despite ongoing fundamental concerns. The stock’s price remained well below its 52-week high of Rs.179.25, underscoring persistent volatility.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
Thursday, 9 April 2026: Minor Pullback Amid Mixed Signals
Themis Medicare edged down 0.27% to Rs.82.57 on lighter volume of 2,880 shares. This slight retreat followed the previous day’s strong rally and reflected the mixed technical signals present in the stock’s profile. While weekly momentum indicators were mildly bullish, monthly MACD and KST remained bearish, indicating longer-term caution.
The Sensex declined 0.49% to 34,521.99, also showing some profit-taking after recent gains. The Relative Strength Index (RSI) remained neutral, suggesting the stock was neither overbought nor oversold, which may have contributed to the sideways price action.
Friday, 10 April 2026: Week Closes with 1.20% Gain
The stock closed the week at Rs.83.56, up 1.20% on the day with volume rising to 6,133 shares. This final session gain helped Themis Medicare secure a weekly advance of 3.87%, though it still lagged behind the Sensex’s 5.34% rise. The positive close was supported by continued mild bullishness in weekly technical indicators and a lack of fresh negative news.
Sensex ended at 35,004.96, buoyed by broad market optimism. Themis Medicare’s performance this week reflected a cautious recovery in technical momentum amid persistent fundamental challenges, including flat financial results and negative profitability trends.
Considering Themis Medicare Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-06 | Rs.80.45 | - | 33,229.93 | - |
| 2026-04-07 | Rs.79.60 | -1.06% | 33,395.05 | +0.50% |
| 2026-04-08 | Rs.82.79 | +4.01% | 34,690.59 | +3.88% |
| 2026-04-09 | Rs.82.57 | -0.27% | 34,521.99 | -0.49% |
| 2026-04-10 | Rs.83.56 | +1.20% | 35,004.96 | +1.40% |
Key Takeaways
Technical Momentum Shows Signs of Stabilisation: The upgrade from ‘Strong Sell’ to ‘Sell’ by MarketsMOJO was driven by improved technical indicators, including a mildly bullish weekly MACD and KST, and a shift from bearish to mildly bearish trends. These signals suggest a tentative easing of downward pressure in the near term.
Fundamental Challenges Persist: Despite technical improvements, Themis Medicare’s financial performance remains subdued. The company reported flat net sales and a 50.60% decline in profit after tax over the latest six months. Negative EBITDA and a negative ROCE highlight ongoing operational difficulties.
Volume and Price Volatility Remain Elevated: Trading volumes fluctuated significantly during the week, with the highest volume on the day of the 4.01% price gain. The stock’s price remains volatile, trading far below its 52-week high and only marginally above its 52-week low.
Underperformance Relative to Sensex: Themis Medicare’s 3.87% weekly gain lagged behind the Sensex’s 5.34% rise, continuing a pattern of underperformance over recent periods. This reflects the stock’s micro-cap status and sector-specific challenges within Pharmaceuticals & Biotechnology.
Conclusion
Themis Medicare Ltd’s week was characterised by a cautious technical recovery amid persistent fundamental headwinds. The MarketsMOJO upgrade to a ‘Sell’ rating reflects improved momentum signals but does not indicate a fundamental turnaround. Investors should remain vigilant given the company’s flat financial trends, negative profitability, and volatile price action. The stock’s micro-cap status and lack of institutional interest further underscore the risks involved. Monitoring upcoming quarterly results and technical developments will be essential to assess any sustained improvement in outlook.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
